Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy
- PMID: 10582199
Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy
Abstract
Sublingual immunotherapy has been suggested for the treatment of respiratory allergies. Many controversial studies have been reported on the efficacy of sublingual immunotherapy. The aim of this prospective study was to evaluate whether sublingual immunotherapy was effective according to clinical and laboratory results in pediatric allergies. Thirty-nine allergic, grass pollen sensitive children were admitted into the study. Sublingual immunotherapy was given over a 12-month period to 21 children (mean age 10.5 +/- 3.3 years), 10 of whom had seasonal allergic rhinitis and 11 seasonal allergic asthma. During the same period, 18 children (mean age 11.1 +/- 2.5 years), 10 with seasonal allergic rhinitis and eight with seasonal allergic asthma, received placebo. Symptom scores and drug requirements were recorded and urine samples were collected to detect urinary levels of leukotrienes (Uc-LTB4 and Uc-LTE4). In patients who received sublingual immunotherapy, the symptom scores of seasonal allergic rhinitis significantly decreased, but no statistically significant changes were observed in terms of symptoms of seasonal allergic asthma. Uc-LTE4 and Uc-LTB4 levels of seasonal allergic rhinitis, with a geometric mean and 95% confidence interval (CI), were significantly decreased from 216 (103-464) and 61 (22-198) pmol/mmol creatinine to 78 (29-159) and 35 (12-118) pmol/mmol creatinine, respectively (p < 0.05 and p < 0.05). On the other hand, Uc-LTE4 and Uc-LTB4 levels for seasonal allergic asthma were 180 (92-355) and 78 (44-258) pmol/mmol creatinine and decreased to 156 (72-402) and 69 (32-254) pmol/mmol creatinine, respectively. These changes were not statistically significant (p > 0.05). According to our clinical results and urinary levels of leukotrienes, which are mediators showing the severity of allergic inflammation, it can be suggested that sublingual immunotherapy may be useful in the treatment of seasonal allergic rhinitis but not of seasonal allergic asthma.
Similar articles
-
Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents.J Investig Allergol Clin Immunol. 2009;19(2):125-31. J Investig Allergol Clin Immunol. 2009. PMID: 19476016 Clinical Trial.
-
Efficacy, safety and tolerability of sublingual monomeric allergoid in tablets given without up-dosing to pediatric patients with allergic rhinitis and/or asthma due to grass pollen.Eur Ann Allergy Clin Immunol. 2009 Dec;41(6):177-80. Eur Ann Allergy Clin Immunol. 2009. PMID: 20128231 Clinical Trial.
-
The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.Pediatr Allergy Immunol. 2006 Sep;17(6):396-407. doi: 10.1111/j.1399-3038.2006.00442.x. Pediatr Allergy Immunol. 2006. PMID: 16925684 Clinical Trial.
-
Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy.Ann Med. 2011;43(6):418-24. doi: 10.3109/07853890.2011.595426. Epub 2011 Jun 17. Ann Med. 2011. PMID: 21679103 Review.
-
[Preventive immunotherapy].Allergol Immunopathol (Madr). 2000 May-Jun;28(3):89-93. Allergol Immunopathol (Madr). 2000. PMID: 10867376 Review. Spanish.
Cited by
-
Sublingual allergen immunotherapy for respiratory allergy: a systematic review.Drugs Context. 2018 Nov 5;7:212552. doi: 10.7573/dic.212552. eCollection 2018. Drugs Context. 2018. PMID: 30416528 Free PMC article.
-
Development of a sublingual allergy vaccine for grass pollinosis.Drug Des Devel Ther. 2010 Jul 21;4:99-105. doi: 10.2147/dddt.s10044. Drug Des Devel Ther. 2010. PMID: 20689696 Free PMC article. Review.
-
Applicability of evidence from previous systematic reviews on immunotherapy in current practice of childhood asthma treatment: a GRADE (Grading of Recommendations Assessment, Development and Evaluation) systematic review.BMJ Open. 2017 Dec 28;7(12):e016326. doi: 10.1136/bmjopen-2017-016326. BMJ Open. 2017. PMID: 29288175 Free PMC article.
-
Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.Curr Allergy Asthma Rep. 2007 Nov;7(6):410-20. doi: 10.1007/s11882-007-0063-6. Curr Allergy Asthma Rep. 2007. PMID: 17986370 Review.
-
Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study.Clin Mol Allergy. 2017 Apr 3;15:7. doi: 10.1186/s12948-017-0064-5. eCollection 2017. Clin Mol Allergy. 2017. PMID: 28392751 Free PMC article.